Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. - Wikidata - awgldk - TriplyDB

Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

http://www.wikidata.org/entity/Q34626551

about

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer Bacterial translocation - impact on the adipocyte compartment Mesenchymal stem cell secretome and regenerative therapy after cancer Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets Tumor entrained neutrophils inhibit seeding in the premetastatic lung Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils Tumors induce complex DNA damage in distant proliferative tissues in vivo Enrichment of murine CD68+ CCR2+ and CD68+ CD206+ lung macrophages in acute pancreatitis-associated acute lung injury Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer Identification of novel markers for the diagnosis of malignant pleural mesothelioma.Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.Systemic DNA damage related to cancer Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Deficiency for the chemokine monocyte chemoattractant protein-1 aggravates tubular damage after renal ischemia/reperfusion injury Anti-CCL2: building a reservoir or opening the floodgates to metastasis?Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response.Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity.Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1 Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages Bone marrow macrophages support prostate cancer growth in bone.Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers.Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.Selective and inducible targeting of CD11b+ mononuclear phagocytes in the murine lung with hCD68-rtTA transgenic systems.Quantitative analysis of tumor burden in mouse lung via MRI Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet Targeting tumor-infiltrating macrophages to combat cancer.Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model.

P2860

Q26779184-6F2B38F1-6999-477E-9749-70A7F202293A Q26796395-EFB5B18F-2846-433A-97DB-80D5E0DB335D Q26849525-E29ED18C-21C8-4748-A34A-338B25657A76 Q26852238-8BF33856-7CB7-42ED-8BE6-DF978C47613E Q27007499-D47F5DCB-AD9E-4355-BA41-4086574467F3 Q28076161-51C5E427-6CC6-47DA-B5E3-A4318B8C05FC Q28247691-88DF61FE-1BCB-4595-82A2-8B6ACB0D2ECE Q33618672-8ED17718-12C7-4E9B-9EB3-5735027B6C39 Q33986185-A9960F30-653A-492D-B497-DE45B408D4C3 Q34142500-09740A77-6A73-44B8-8F84-C81CC01284B7 Q34163579-94438480-16E0-46C4-A8FF-8C405E95C661 Q34241433-36545348-7068-419D-BA50-0A377365CD1E Q34460261-29A52A04-70F0-4E8B-B717-AA6718D6A05A Q34634293-659266D3-CD31-4010-8B84-437719892429 Q34746658-AEA57B38-BBB7-4349-B072-76B661616639 Q34760760-90B82B99-B0C2-4432-8312-B72F4926C753 Q34963525-8F1A16A6-FCF9-4A4B-8524-BAAD48FE8A0A Q34988152-6B058AB5-1ED3-4A51-B96D-EB10117C8B19 Q35582297-738AECEA-3F16-44AE-9C5A-A82C87F534FE Q35602317-9FC66C8F-3542-46E7-9667-F0C4DFA7B285 Q35627081-21FF36B4-7564-4B00-8A6A-5C074867C54E Q35782923-476D794D-42EA-448A-8E63-B3A7C1E982BD Q35799198-AFB54415-D1CB-4C4D-B90F-0A0784EBB941 Q35876239-BD1C088A-C10C-4230-BC13-1506059E2972 Q36125878-EB862427-0631-45B9-B7A5-B4C4F20F90B9 Q36454265-B0E19FCB-CDAD-4934-AD0E-FEEE4A785044 Q36480181-8CC13CDB-610A-43B1-9AA1-B1978F44F1A7 Q36527253-CED3EAC5-A7C0-4FC3-8EC6-1E253589F4E3 Q36527922-6DB2B98C-6D64-48DE-AB7D-DA7D49027F56 Q36545368-A8EE76C6-6C6C-4CE2-A3CC-0FFD892DC90C Q36546464-146134F9-DA41-4403-AC23-3AA1171C47BB Q36709856-7CCFD2C5-A161-426B-A3DF-EC096E2CCEDE Q37117835-39D49517-C9C6-470A-835A-0EF4507C1DD8 Q37139571-90A4CF67-C335-402A-AB21-6DDEA5F7D844 Q37259411-2E75899B-97C8-41F3-820D-8E1C8187DD48 Q37269450-0F867F0E-A2A2-4B29-A962-A4F27F83EEA8 Q37401717-5A1ACD66-ADCB-4ECE-80B5-DD9E89490817 Q37945300-E4DD779A-6161-4F16-ADA9-3BBBC9E87174 Q38016208-0B1CDC91-BD71-48C4-8D1B-2D71D11A20B9 Q38459252-84BF03B9-1B52-4211-AE87-7BA151941919

P2860

Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

http://www.wikidata.org/entity/Q34626551

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@ast

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@en

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@nl

type

label

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@ast

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@en

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@nl

prefLabel

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@ast

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@en

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@nl

P1433

Q34626551-086E0733-E62E-4A6F-8421-6AF9DB5A548F

P1476

Q34626551-E73C066C-4E23-40DD-A076-C8A2F3488960

P2093

Q34626551-2D171375-9E9A-4884-B5A5-D845E5D54D58

Q34626551-53BA85A7-D747-4A4D-80DE-ACABFD4DA57C

Q34626551-557E8B7F-9A4E-4F0B-BE71-37B4F0762469

Q34626551-65463198-AAFB-4B89-9A5C-786F840182AA

Q34626551-831D17F7-F736-49B5-889F-A45BA3AE0BB7

Q34626551-A4761A74-D22C-47C2-ACD9-DD8D4062C529

Q34626551-C7195092-CF4B-4F95-A3C7-15FE32E0604F

Q34626551-C9A993E2-8296-4BF1-A6C2-B07B81454F09

Q34626551-CD36A667-46FB-4451-9123-B8BBA5D8DAED

P2860

Q34626551-0042FD9C-4790-45B9-8F25-B8DAFA74E236

Q34626551-07B0FECC-F280-4CC2-BF15-4EE1C8E8B168

Q34626551-0CF836CD-FFB6-455E-8788-7937F06BCAE8

Q34626551-0F1DB93C-0DB5-452D-91C2-6EC77650B390

Q34626551-1DC0E84E-24CF-4B9B-8730-901BDB05A9E8

Q34626551-1E33F3DE-AB01-4EA9-9BEC-18BBE9412E9A

Q34626551-28C2DBAF-BFA6-4B7E-9425-39018BCBC12A

Q34626551-2DBFBFC3-4719-4E24-8573-8B339B37EBE0

Q34626551-2E70F04C-4E3A-4FA6-B1E7-958288CE1850

Q34626551-2F833843-8F8F-48E2-B80E-A7DA7B5BF51E

P304

Q34626551-23CD0E41-3529-44CA-B987-62A0C54E6A9A

P31

Q34626551-4F22E934-3172-497F-932F-E1919C4941D2

P356

Q34626551-CD2721C3-DC91-4084-93F1-923CE409A16F

P433

Q34626551-128BE343-950F-4523-A5FC-2556BE751660

P478

Q34626551-159B5CEA-524E-48CC-96A9-04DB0E1D3CEA

P577

Q34626551-AB40B768-F86A-45CB-829B-5F54FB73B734

P698

Q34626551-0D036EC5-4478-4D1C-ACE2-A707DBA939A6

P921

Q34626551-800EC8EA-166F-4FB2-87E9-9E07F1F73138

P932

Q34626551-F4941D74-FD1F-461D-A2A0-4C61C3569DCC

P356

RCMB.2010-0080OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Monocyte chemoattractant prote ...... ype and activating CD8+ cells.

@en

P2093

George Buchlis

http://www.w3.org/2001/XMLSchema#string

Guanjun Cheng

http://www.w3.org/2001/XMLSchema#string

Jing Sun

http://www.w3.org/2001/XMLSchema#string

Liang-Chuan S Wang

http://www.w3.org/2001/XMLSchema#string

Linda A Snyder

http://www.w3.org/2001/XMLSchema#string

Steven M Albelda

http://www.w3.org/2001/XMLSchema#string

Sunil Singhal

http://www.w3.org/2001/XMLSchema#string

Veena Kapoor

http://www.w3.org/2001/XMLSchema#string

Zvi G Fridlender

http://www.w3.org/2001/XMLSchema#string

P2860

Generation, characterization and biological activity of CCL2 (MCP-1/JE) and CCL12 (MCP-5) specific antibodies

Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1

Monocyte and macrophage heterogeneity

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Immunosuppressive strategies that are mediated by tumor cells

CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization

CCL2 blockade augments cancer immunotherapy.

Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.

Modeling metastasis in vivo.

P304

230-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2010-0080OC

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20395632

http://www.w3.org/2001/XMLSchema#string

P921

P932

3049234

http://www.w3.org/2001/XMLSchema#string